Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112898202A details a mild visible-light photocatalytic method for synthesizing heterocyclyl cyclopropane compounds, offering significant advantages for pharmaceutical intermediate manufacturing.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel metal-free visible light catalytic method for 1,2,3,4-tetrahydronaphthalene intermediates. Offers high atom utilization and mild conditions for pharma manufacturing.
Patent CN117247370A enables room-temperature thioflavonoid synthesis using CO2. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN114874139A details a green visible-light method for synthesizing dihydroisoquinoline intermediates, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN108299296A details a visible-light induced synthesis of phenanthridine derivatives using organic photocatalysts, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN111072605B details a visible-light catalyzed method for fluoroalkyl-substituted benzofurans. Offers mild conditions and high yields for pharma intermediates.
Patent CN117164492B enables metal-free synthesis of high-purity vinyl selenone compounds. Achieve cost reduction and supply reliability in pharmaceutical intermediate manufacturing.
Patent CN110540516B details a mild visible-light protocol for dihydronaphthalenes, offering cost-effective routes for pharmaceutical intermediates.
Patent CN110540516B reveals visible-light mediated synthesis of dihydronaphthalenes. High yield, mild conditions, reliable pharmaceutical intermediate supplier.
Patent CN117164492B details metal-free photocatalytic synthesis. Offers high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN114805209B details a metal-free photocatalytic route for 3-aryl-2H-indazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel Rose Bengal catalyzed method for alpha-indole glycine derivatives offers green, scalable production for pharmaceutical intermediates.
Patent CN111892545A reveals a green photocatalytic route for quinoxalinones. Achieve high yields without transition metals, ensuring cost reduction in API manufacturing and reliable supply.
Patent CN112898202B discloses a mild photocatalytic route to heterocyclic cyclopropanes. This technology offers cost reduction in pharmaceutical intermediate manufacturing through scalable, visible-light catalysis.
Patent CN117088826B enables visible light synthesis of oxazoles. Offers green chemistry solutions for reliable pharmaceutical intermediates supplier partners seeking cost reduction.
Novel visible light photocatalysis method for C2-difluoroalkylbenzimidazole derivatives offers mild conditions and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN105669522B reveals metal-free visible light synthesis for high-purity indolinones offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel visible-light catalyzed method for 3-alkyl quinoxalin-2(1H)-ones. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Novel visible-light driven Ru-catalyst enables room-temp alkyne-aldehyde addition. Reduces energy costs and simplifies supply chain for API synthesis.